CollPlant Biotechnologies (CLGN) Competitor Comparison
We are evaluating the key criteria listed to compare CollPlant Biotechnologies (CLGN) against its competitors in the Biotechnology industry.
Market Capitalization
286 / 368Gross Profits
0 / 278Total Revenue
184 / 300EBITDA
43 / 337Free Cashflow
56 / 352Quick Ratio
65 / 357Earnings per Share
174 / 359Dividend yield
0 / 6Total Cash
286 / 358Performance 3 years
221 / 368Performance 5 years
157 / 368Performance 10 years
161 / 368Linearity 3 years
154 / 368Linearity 5 years
46 / 368Linearity 10 years
89 / 367Total Rank
91 / 368Dividend Rank
8 / 368Valuation Rank
297 / 368Piotroski Rank
270 / 368Muliplier Rank
315 / 368Market Capitalization - CLGN ranking 286 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.